Why Centene (CNC) Is Getting Fresh Attention
Centene (CNC) drew fresh attention after reporting second quarter 2026 results that showed higher revenue and a shift to net income, along with raised full year revenue and earnings guidance on July 28.
See our latest analysis for Centene.
Centene's recent earnings release and raised full year guidance appear to be feeding into strong momentum, with a 7 day share price return of 4.41% and year to date share price return of 59.33%, while the 1 year total shareholder return of 163.64% contrasts with much flatter 3 and 5 year total shareholder returns.
If Centene's move has you looking across healthcare for other ideas, this could be a good moment to review 43 healthcare AI stocks.
Centene now appears to be a stronger business following its recent earnings and guidance shift. After such a sharp share price move, the key question is whether the stock still offers sensible value or whether it now prices in too much good news.
Most Popular Narrative: 4.4% Overvalued
Centene's most followed valuation narrative pegs fair value at $63.78, which sits slightly below the recent $66.57 close, so it frames the current move as a modest premium.
Analysts are assuming Centene's revenue will grow by 4.0% annually over the next 3 years. Analysts assume that profit margins will increase from 3.6% today to 1.3% in 3 years time.
Want to see what is baked into that Centene fair value? The narrative leans on steady top line growth, a sharp earnings swing, and a tighter profit profile. The mix of growth and margins behind that view may surprise you.
Result: Fair Value of $63.78 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Centene's story still carries real execution risk, particularly around Medicaid rate adequacy and medical cost pressures from issues like specialty drugs and unexpected spikes in illness.
Find out about the key risks to this Centene narrative.
Another View on Centene's Valuation
The SWS DCF model paints a very different picture for Centene. At a recent share price of $66.57, the stock is described as trading about 64.7% below an estimated future cash flow value of $188.62, which implies a large upside gap versus the analyst fair value of $63.78. Which story do you trust more?
Look into how the SWS DCF model arrives at its fair value.
Next Steps
With mixed signals on Centene's valuation story, this is a good time to review the underlying assumptions, weigh the trade offs, and stress test the risks and rewards for yourself. To see the full picture in one place, including the balance of potential upside and downside, start by reviewing the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Centene?
If Centene has sharpened your focus, do not stop here. The Simply Wall St Screener can help you quickly surface fresh stock ideas that fit your style.
- Target potential bargains with healthy fundamentals by scanning a focused set of 52 high quality undervalued stocks that combine quality metrics with appealing price tags.
- Prioritise resilience by reviewing 83 resilient stocks with low risk scores that score well on financial strength and historically lower risk characteristics.
- Spot earlier stage opportunities by checking the 20 elite penny stocks with strong financials that pass strict filters on balance sheets and financial quality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com